Janssen Pharmaceutica, a member of MEDVIA, is offering the free day-long symposium Next-Generation Cell Therapy on 22 June in the Janssen Café in Beerse. A full program of speakers will discuss state-of-the-art research in next-generation cell-based therapies with a specific focus on allogeneic cell therapies and logic-gated chimeric antigen receptors.
Next-Generation Cell Therapy
22 June 8.00-18.00
With advancements in technology and research, the next generation in cell therapies is emerging as a promising approach for effective treatment across a wide range of diseases. The symposium also aims to explore the challenges that lie ahead, including manufacturing.
Among the many speakers are:
- Michael Hudecek, professor of translational CAR-T research at the University of Würzbürg
- Maria Themeli, assistant professor of cancer biology and immunology at Amsterdam University Medical Center
- Marc Davies, Vice-president of CAR engineering at the London-based Leucid Bio